Investor profile
Eli Lilly has backed 2 European tech companies across 2 funding rounds between 2024 and 2025, joining rounds totalling €102M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Orbis Medicines | Denmark | 1 | €90M |
| NanoSyrinx | UK | 1 | €12M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Orbis Medicines | Series A | €90M | 2025-01 |
| NanoSyrinx | Other | €12M | 2024-09 |
